NIKKI GREER-COLLIER: Open Payments
NPI 1144894791 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,491 in 129 payments from 42 companies in 2025. Trend: 2023 $2,695 · 2024 $2,796 · 2025 $3,491
Food & beverage: $2,714Long term medical supply or device loan: $499Education: $278
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $686 |
| Janssen Biotech, Inc. | 8 | $239 |
| Regeneron Healthcare Solutions, Inc. | 6 | $194 |
| AstraZeneca Pharmaceuticals LP | 8 | $180 |
| Incyte Corporation | 5 | $153 |
| Gilead Sciences, Inc. | 3 | $151 |
| Genentech USA, Inc. | 9 | $143 |
| Merck Sharp & Dohme LLC | 6 | $125 |
| Exelixis Inc. | 2 | $121 |
| Astellas Pharma US Inc | 5 | $116 |
Products named: KISQALI, Trodelvy, LIBTAYO, RYBREVANT, KEYTRUDA, ENHERTU, Vyloy, Nubeqa.
Industry payments across TN — which companies pay providers there.
